Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-047721

Chief Financial Officer bought 90,300 shares at an average $2.54 ($229,747)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2022-08-24 Purchase +50,000 $2.50 $125,225 205,452 D: show line 1 in the form
Byam Rebecca Chief Financial Officer 2022-08-25 Purchase +40,300 $2.59 $104,522 245,752 D: show line 2 in the form
Open-market purchases · 90,300 sh · avg $2.54 · $229,747
Loading xslF345X03/doc4.xml…